Yue Lu

1.5k total citations
51 papers, 1.2k citations indexed

About

Yue Lu is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Yue Lu has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 17 papers in Immunology. Recurrent topics in Yue Lu's work include Lymphoma Diagnosis and Treatment (24 papers), Viral-associated cancers and disorders (14 papers) and Immune Cell Function and Interaction (12 papers). Yue Lu is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Viral-associated cancers and disorders (14 papers) and Immune Cell Function and Interaction (12 papers). Yue Lu collaborates with scholars based in China and United States. Yue Lu's co-authors include Zhong-Jun Xia, Liang Wang, Hua Wang, Hui-Qiang Huang, Qi-rong Geng, Hua Wang, Jing‐Hua Wang, Wen-Qi Jiang, Zhongjun Xia and Weida Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Yue Lu

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yue Lu China	20	683	436	432	278	178	51	1.2k
Brent Tan United States	10	586 0.9×	780 1.8×	222 0.5×	365 1.3×	106 0.6×	26	1.4k
Cristiana Carniti Italy	21	439 0.6×	314 0.7×	245 0.6×	396 1.4×	392 2.2×	59	1.2k
Martin Kornacker Germany	20	564 0.8×	399 0.9×	317 0.7×	380 1.4×	138 0.8×	59	1.3k
Rosaria De Filippi Italy	19	467 0.7×	386 0.9×	453 1.0×	307 1.1×	102 0.6×	61	1.2k
Yong‐Oon Ahn South Korea	21	676 1.0×	646 1.5×	133 0.3×	336 1.2×	126 0.7×	45	1.4k
Ana Pilar González Spain	17	524 0.8×	491 1.1×	286 0.7×	164 0.6×	109 0.6×	45	1.0k
Teresa Flores Spain	19	492 0.7×	191 0.4×	414 1.0×	539 1.9×	255 1.4×	25	1.3k
Juehua Gao United States	16	253 0.4×	233 0.5×	321 0.7×	339 1.2×	197 1.1×	60	1.1k
Colm Keane Australia	21	778 1.1×	586 1.3×	645 1.5×	294 1.1×	66 0.4×	84	1.4k

Countries citing papers authored by Yue Lu

Since Specialization

Citations

This map shows the geographic impact of Yue Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Lu more than expected).

Fields of papers citing papers by Yue Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Lu. The network helps show where Yue Lu may publish in the future.

Co-authorship network of co-authors of Yue Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Lu. A scholar is included among the top collaborators of Yue Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Lu. Yue Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Ruonan, Shuang Liu, Wenjian Liu, et al.. (2024). Interleukin‐33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species‐mediated inhibition of nuclear factor kappa‐B signal and stemness properties. SHILAP Revista de lepidopterología. 5(5). e562–e562. 5 indexed citations

Wang, Huizhong, Biyun Chen, Ruonan Shao, et al.. (2022). A new prediction model integrated serum lipid profile for patients with multiple myeloma. Journal of Cancer. 13(6). 1796–1807. 12 indexed citations

Wang, Huizhong, et al.. (2022). Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment. Cancer Cell International. 22(1). 187–187. 3 indexed citations

Wang, Yang, Hua Wang, Weida Wang, et al.. (2020). Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients. BMC Cancer. 20(1). 732–732. 7 indexed citations

Wang, Hua, et al.. (2019). <p>NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization</p>. Cancer Management and Research. Volume 11. 4577–4595. 16 indexed citations

Tao, Ran, Fan Liu, Yue Lu, et al.. (2018). A prospective comparative study of hip resurfacing arthroplasty and large-diameter head metal-on-metal total hip arthroplasty in younger patients—a minimum of five year follow-up. International Orthopaedics. 42(10). 2323–2327. 12 indexed citations

Liu, Chengcheng, Hua Wang, Weida Wang, et al.. (2018). ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia. Cellular Physiology and Biochemistry. 46(4). 1525–1535. 65 indexed citations

Wang, Hua, et al.. (2017). High Serum Level of Interleukin-15 Predicts Poor Prognosis in Adult Standard-Risk Acute Lymphoblastic Leukaemia. Blood. 130. 5123.

Wang, Hua, et al.. (2016). The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study. Journal of Cancer Research and Clinical Oncology. 142(11). 2339–2345. 29 indexed citations

10.

Wang, Hua, et al.. (2016). High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma. British Journal of Cancer. 114(4). 463–468. 52 indexed citations

11.

Wang, Hua, et al.. (2016). Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study. Scientific Reports. 6(1). 39463–39463. 6 indexed citations

12.

Xia, Zhongjun, Hua Wang, Liang Wang, et al.. (2016). Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients. OncoTargets and Therapy. 9. 587–587. 8 indexed citations

13.

Wang, Zhao, et al.. (2015). CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Tumor Biology. 36(10). 7717–7723. 15 indexed citations

14.

Wang, Hua, Pengfei Li, Liang Wang, et al.. (2015). High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type. Annals of Hematology. 94(9). 1535–1544. 24 indexed citations

15.

Wang, Liang, Zhong-Jun Xia, Yue Lu, & Yu‐Jing Zhang. (2014). Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type. Medical Oncology. 32(1). 320–320. 5 indexed citations

16.

Wang, Hua, Zhihui Wang, Li Su, et al.. (2014). Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study. Leukemia & lymphoma. 56(4). 971–977. 23 indexed citations

17.

Zhang, Jing, Hua Wang, Liang Wang, et al.. (2013). Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway. Oncology Letters. 7(2). 361–368. 2 indexed citations

18.

Wang, Liang, et al.. (2012). Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. International Journal of Hematology. 96(5). 617–623. 42 indexed citations

19.

Wang, Hua, Qi-rong Geng, Liang Wang, & Yue Lu. (2011). Curcumin potentiates antitumor activity ofl-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leukemia & lymphoma. 53(7). 1376–1382. 23 indexed citations

20.

Lu, Yue, et al.. (2006). In vitro effect of adenovirus‐mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematological Oncology. 24(3). 151–158. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact